Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX for Forehead Lines in China
NCT06174688Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Dec 2023
- Primary completion
- Sep 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin, sponsored by AbbVie Inc.. Started Dec 2023; status: completed.
02
Drugs
botulinum toxin
Beyond the preview
Go deeper on NCT06174688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06174688.